CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
High ImpactOriginal article

IONS Stock Jumps 4% After-Hours — Goldman Sachs Lifts Price Target On Tryngolza Approval

RegulatoryapprovedTryngolzaPositive
AI Analysis

Summary

Ionis Pharmaceuticals' stock jumped 4% after-hours following FDA approval of Tryngolza. Goldman Sachs lifted its price target on the company in response to the approval.

Importance:8/10
Sentiment:
0.80
FDA approvalstock movementprice target increaseanalyst upgrade
Related Companies

Read the original article

Published by yahoo_finance on June 24, 2026 11:54 PM

Read Original